MAIA
MAIA Biotechnology, Inc.
Key Financials
Revenue
$0
NaN%
Operating Income
$-24269686
↓ 43.1%
Net Income
$-22396172
↑ 3.7%
Total Assets
$9.7M
↓ 4.4%
EPS (Diluted)
$-0.70
↑ 33.3%
Shareholders' Equity
$2.4M
↓ 34.6%
Cash & Equivalents
$0.00
NaN%
Long-term Debt
$0.00
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 4/16/2026 | View on SEC |
| 4 | 4/14/2026 | View on SEC |
| 4 | 4/14/2026 | View on SEC |
| 4 | 4/14/2026 | View on SEC |
| 8-K | 4/8/2026 | View on SEC |
| S-8 | 4/7/2026 | View on SEC |
| ARS | 4/7/2026 | View on SEC |
| DEFA14A | 4/7/2026 | View on SEC |
| DEF 14A | 4/7/2026 | View on SEC |
| 4 | 4/2/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MAIA |
| Company Name | MAIA Biotechnology, Inc. |
| CIK | 1878313 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 312-416-8592 |